| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Former Director
2 companies
Patel Sunil is a Director at OmniAb, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 2 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2022 | OABI Omniab, Inc. | Director | Buy | 43,000 | $2.77 | $119,110.00 | +24.9% | +45.7% | +58.0% | |
| Nov 2, 2020 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 1,000 | $82.52 | $82,520.00 | +3.7% | - | - | |
| Aug 2, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 1,000 | $95.98 | $95,980.00 | +3.9% | - | - | |
| Aug 16, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 42,287 | $240.05 | $10,150,808.29 | -63.3% | - | - | |
| Mar 19, 2015 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 4,591 | $74.42 | $341,662.22 | -11.0% | - | - |